The largest database of trusted experimental protocols

Gentra puregene tissue kit

Manufactured by Qiagen
Sourced in Germany, United States, Netherlands, United Kingdom, Canada, Spain

The Gentra Puregene Tissue Kit is a laboratory product designed for the purification of genomic DNA from a variety of tissue samples. It utilizes a simple and efficient protocol to extract high-quality DNA for use in various downstream applications.

Automatically generated - may contain errors

233 protocols using gentra puregene tissue kit

1

DNA Isolation from Starved C. elegans

Check if the same lab product or an alternative is used in the 5 most similar protocols
DNA was isolated from starved OP50 NGM plates with WT(drIs4) or mutant animals using the Qiagen Gentra Puregene Tissue Kit (Cat No 158667). The supplementary protocol for “Purification of archive-quality DNA from nematode suspensions using the Gentra Puregene Tissue Kit” available from Qiagen was used to isolate DNA. DNA samples were sequenced by BGI Americas (Cambridge, MA) with 20X coverage and paired-end reads using the Illumina HiSeq X Ten System.
+ Open protocol
+ Expand
2

Whole Exome Sequencing of Frozen Tissue

Check if the same lab product or an alternative is used in the 5 most similar protocols
Genomic DNA from frozen tissue was extracted using the Qiagen Gentra Puregene Tissue Kit (Qiagen). Sequencing libraries were prepped with the KAPA HyperPrep Kit (Roche) using 1 µg of DNA. DNA was sheared using a Covaris LE220 ultrasonicator targeting 200 bp, and sequencing adaptors added by ligation. Individually barcoded libraries were pooled 4-plex before capture. Libraries were hybridized to SeqCap EZ Choice probes of the 50 Mb Human UTR Design (Roche), and sequenced on a HiSeq 2500 (Illumina) using a PE100 in high-output mode. Image analysis and base calling were performed using Illumina’s Real Time Analysis v1.18.66.3 software, followed by demultiplexing of indexed reads and generation of FASTQ files, using Illumina’s bcl2fastq Conversion software v1.8.4.
+ Open protocol
+ Expand
3

Genomic DNA Extraction from Mouse Liver

Check if the same lab product or an alternative is used in the 5 most similar protocols
Genomic DNA from mice exposed to DOX was extracted with the QIAGEN Gentra Puregene Tissue Kit (Qiagen Sciences) following the manufacturer’s instructions with minor modifications. In brief, frozen liver tissues (270–390 mg) were minced with a razor blade while on dry ice. The minced tissues were lysed with 3 mL cell lysis solution and incubated for 5 min on ice to allow for degradation. The tissue was then homogenized using a tissue homogenizer set at low-medium speed for no more than 1 min. Additional 3 mL of cell lysis solution were added and mixed by inverting 25 times. Next, 30 μl of Proteinase K (20 mg/mL) were added and tubes were mixed by inverting 25 times and incubated overnight in a shaker at room temperature. A total of 30 μl RNase A solution (4 mg/mL) was added to each lysate and mixed before incubation for 2 h in a shaker at room temperature. Then, 2 mL of protein precipitation solution were added and tubes were vortexed vigorously for 20 s prior to centrifugation (2500 x g for 15 min). Supernatants were added to cold IPA, and DNA was precipitated and washed as previously described, with the only difference being the DNA pellets were air-dried. The DNA pellets were stored at − 20 °C. The amounts described above were reduced by a factor of 4 when using 50 mg of liver tissue.
+ Open protocol
+ Expand
4

Genomic DNA Extraction and Validation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mouse genomic DNA was extracted from toe or ear samples using the Qiagen Gentra Puregene Tissue Kit (Qiagen Sciences, Maryland, USA) or Allele-In-One Mouse Tail Direct Lysis Buffer (KURABO, Osaka, Japan). Primers were designed to amplify the correctly targeted junctions. Genomic DNA was subjected to flanking primer PCR and internal (donor oligo-specific) and external primer PCR. The primer sequences for all 13 genes are listed in Additional file 1: Table S1. PCR reactions were performed using the Go Taq Promega Hot Start green mix (Promega, Madison, WI, USA) or PrimeSTAR HS DNA Polymerase (TaKaRa, Shiga, Japan). The amplicons were separated on a 1–3% agarose gel. The gel-purified amplicons were subjected to sequencing using one of the PCR primers and/or internal primers. In some cases, PCR products were cloned into TA (Life Technologies, catalog number K2020-20) vectors before sequencing.
+ Open protocol
+ Expand
5

Equine DNA Extraction Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
DNA was extracted from the hair samples of Australian Thoroughbred horses using the Qiagen Gentra Puregene Tissue Kit (Qiagen, Redwood City, CA, USA). DNA was extracted from the hair samples of Norwegian-Swedish Coldblooded Trotters and Swedish Warmbloods by incubating the samples for 2 h at 56 °C with Chelex 100 Resin (Bio-Rad Laboratories, Hercules, CA) and Proteinase K (20 mg/mL; Merck KgaA, Darmstadt, Germany). The Proteinase K was then inactivated by incubating for 10 min at 95 °C and DNA resuspended in low TE (1 mM Tris, 0.1 mM EDTA). DNA was extracted from blood samples using the Qiasymphony DSP DNA mini kit (Qiagen, Hilden, Germany).
+ Open protocol
+ Expand
6

Quantitative Analysis of MET and FAM3C Copy Number in Colorectal Carcinoma

Check if the same lab product or an alternative is used in the 5 most similar protocols
Genomic DNA was isolated from non-stromal regions of 3–4 10 μm thick sections of formalin fixed paraffin-embedded tumors of 49 advanced-stage colorectal carcinoma patients using the Gentra Puregene Tissue Kit (Qiagen) according the manufacturer’s instructions. 60 ng of isolated genomic DNA was used as template in the quantitative real-time PCR reaction. All samples were done in triplicates and the MET and FAM3C copy numbers were derived by standardizing the input DNA to the control signal (TOP3A, chromosome 17p11) as described earlier [15 (link)]. The sequences of the primer pairs and probes for TOP3A and MET were as described in [16 (link)] using FAM as flourogenic label. For FAM3C the primers Hsp.FAM3C_F 5′-GTCACACTCTTGTGCCAGTCT-3′ and Hsp.FAM3C_R 5′-GAGCAAAGGTCAGGGTTGAAAG-3′ were used with the HEX-labeled probe Hsp.FAM3C_probe 5′-TCTGCAGCTTCAAATCCCCTCCTG-3′ allowing duplex PCR with the TOP3A control gene.
+ Open protocol
+ Expand
7

CRISPR/Cas9 Mutation Detection Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
CRISPR/Cas9-mediated mutations were detected using the T7 Endonuclease I (New England Biolabs). Briefly, genomic DNAs was isolated using Gentra Puregene Tissue Kit (Qiagen) in accordance to manufacturer’s protocol. An approximately 700 bp region surrounding the CRISPR/Cas9-targeted site was amplified using the Q5 Hot Start DNA Polymerase (New England Biolabs), column-purified (Qiagen) and subjected to a series of melting and annealing cycles with the annealing temperature gradually lowered in each successive cycle. T7 Endonuclease I was then added to selectively digest heteroduplex DNA. Digest products were visualised on a 2%–3% agarose gel.
Alternatively, Sanger nucleotide sequencing analysis was performed on PCR products using a T7 primers to detect mutations.
+ Open protocol
+ Expand
8

Tissue Preservation and Nucleic Acid Extraction

Check if the same lab product or an alternative is used in the 5 most similar protocols
Freshly excised surgical specimens were stored in RNAlater™ Solution (Thermo Fisher Scientific, MA, USA) at 4°C for 24 h and subsequently frozen at −80°C prior to RNA extraction. We used either the manual method using TRIzol reagent (Invitrogen, Carlsbad, CA) according to the manufacturer’s instruction or the automated method using the gentleMACS™ Octo Dissociator with Heaters (Miltenyi Biotec, Gladbach, Germany) for homogenization and the Maxwell™ RSC simplyRNA Tissue Kit (Promega Corporation, Madison, WI, USA) for total RNA extraction. For DNA extraction, freshly excised surgical specimens were stored at −80°C. Two extraction methods were utilized, including the manual method using the Gentra Puregene Tissue Kit (Qiagen, Venlo, Netherlands) according to the manufacturer’s instruction and the automated method using the gentleMACS™ Octo Dissociator with Heaters (Miltenyi Biotec, Gladbach, Germany) for homogenization and the Maxwell™ RSC blood DNA Kit (Promega Corporation, Madison, WI, USA).
+ Open protocol
+ Expand
9

Colon Cancer Tissue Sampling and DNA Extraction

Check if the same lab product or an alternative is used in the 5 most similar protocols
Archival tissue samples were selected that would reflect a wide range of treatment conditions, genotypes, and pathological stages. Multiple specimens were analysed for some mice. These included adenocarcinomas and dysplastic tumors from the distal colon and normal tissue from different parts of the colon. Specimens were manually microdissected from formalin-fixed paraffin embedded tissue that had been scored by a specialist Anatomical Pathologist (JED). DNA was isolated using a modified protocol of the Gentra Puregene Tissue Kit (Qiagen).
+ Open protocol
+ Expand
10

Targeted Exome Sequencing for Genomic Alterations

Check if the same lab product or an alternative is used in the 5 most similar protocols
Genomic DNAs from flash-frozen tissue samples were extracted using the Gentra Puregene Tissue Kit (Qiagen) according to the manufacturer’s protocols. Deep-targeted exome sequencing of 263 genes (T200) was used to evaluate genomic alterations in 54 samples as described(14 (link)). Since matched normal tissue was not available, we used a common normal control sample to identify single nucleotide variants by MuTect and small insertions and deletions by Pindel (15 (link),16 (link)). To reduce false positives, outputs generated by MuTect and Pindel were filtered by the following approaches: (1) removal of novel mutations with VAF>0.4 and documented mutations from COSMIC with VAF>0.6, (2) removal of known SNP and exon variants as well as polymorphic genes with VAF<0.4, and (3) sequencing depth of at least 100 reads for documented mutations and 300 reads for novel mutations. The filtering criterion for VAF was chosen after manual curation of mutations selected with different VAF thresholds. Hits found across many samples were manually curated to reduce the rate of false positive mutations.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!